Neutralizing antibodies following three doses of BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron predominant wave

Shohei Yamamoto; Kouki Matsuda; Kenji Maeda; Kumi Horii; Kaori Okudera; Yusuke Oshiro; Natsumi Inamura; Junko S. Takeuchi; Maki Konishi; Mitsuru Ozeki; Tetsuya Mizoue; Haruhito Sugiyama; Nobuyoshi Aoyanagi; Hiroaki Mitsuya; Wataru Sugiura; Norio Ohmagari

doi:10.1101/2022.09.15.22280009

Neutralizing antibodies following three doses of BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron predominant wave

View ORCID ProfileShohei Yamamoto, Kouki Matsuda, Kenji Maeda, Kumi Horii, Kaori Okudera, Yusuke Oshiro, Natsumi Inamura, View ORCID ProfileJunko S. Takeuchi, Maki Konishi, Mitsuru Ozeki, Tetsuya Mizoue, Haruhito Sugiyama, Nobuyoshi Aoyanagi, Hiroaki Mitsuya, Wataru Sugiura, Norio Ohmagari

doi: https://doi.org/10.1101/2022.09.15.22280009

Shohei Yamamoto

1Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Shohei Yamamoto
For correspondence: syamamoto@hosp.ncgm.go.jp

Kouki Matsuda

2Department of Refractory Viral Infection, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan

3AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kenji Maeda

4Department of Refractory Viral Infection, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan

5Division of Antiviral Therapy, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kumi Horii

6Infection Control Office, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kaori Okudera

7Infection Control Office, Kohnodai Hospital of the National Center for the Global Health and Medicine, Chiba, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yusuke Oshiro

8Department of Laboratory Testing, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Natsumi Inamura

8Department of Laboratory Testing, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Junko S. Takeuchi

9Department of Academic-Industrial Partnerships Promotion, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Junko S. Takeuchi

Maki Konishi

1Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mitsuru Ozeki

8Department of Laboratory Testing, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Tetsuya Mizoue

1Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: mizoue@hosp.ncgm.go.jp

Haruhito Sugiyama

10Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nobuyoshi Aoyanagi

11Kohnodai Hospital of the National Center for the Global Health and Medicine, Chiba, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hiroaki Mitsuya

4Department of Refractory Viral Infection, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Wataru Sugiura

12Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Norio Ohmagari

13Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Abstract
Full Text
Info/History
Metrics
Data/Code
Preview PDF

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

View the discussion thread.

PreviousNext

Posted September 17, 2022.

Download PDF

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Neutralizing antibodies following three doses of BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron predominant wave

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Neutralizing antibodies following three doses of BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron predominant wave

Shohei Yamamoto, Kouki Matsuda, Kenji Maeda, Kumi Horii, Kaori Okudera, Yusuke Oshiro, Natsumi Inamura, Junko S. Takeuchi, Maki Konishi, Mitsuru Ozeki, Tetsuya Mizoue, Haruhito Sugiyama, Nobuyoshi Aoyanagi, Hiroaki Mitsuya, Wataru Sugiura, Norio Ohmagari

medRxiv 2022.09.15.22280009; doi: https://doi.org/10.1101/2022.09.15.22280009

Share This Article: